Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 28(2): 400-404, 2020 Apr.
Article in Chinese | MEDLINE | ID: mdl-32319369

ABSTRACT

OBJECTIVE: To investigate the differentiation of acute promyelocytic leukemia (APL) cells induced by Tetrandrine targeting MUC1. METHODS: HL-60 cells at logarithmic growth phase were choosen as object of reaserch and were divided into four groups: control, ATRA, Tetrandrine and ATRA+Tetrandrine group. Cell morphologic changes in each group were observed by microscopy. The change of cell differentiation ability was analyzed by nitro-blue tetrazolium (NBT) reduction test. The expression of cell surface differentiation antigen CD11b was measured by flow cytometry. The expression of MUC1 protein was detected by Western blot. RESULTS: The differentiation of HL-60 cell could be induced by Tetrandrine. The NBT reduction-positive rate of ATRA+Tetrandrine group was significantly higher than that in ATRA group and Tetrandrine group (P<0.05). The percentage of CD11b positive cells in ATRA+Tetrandrine group(43.62%±1.38%) was significantly higher than that in Tetrandrine group(15.25%±2.11%), ATRA group (28.84%±7.53%) and control group(8.16%±1.01%) (P<0.05). The content of MUC1 protein in Tetrandrine group was significantly lower than that in control group and ATRA group (P<0.05). CONCLUSION: Tetrandrine and ATRA can synergize to promote the differentiation and maturation of HL-60 cells, and the mechanism may be related with MUC1 expression.


Subject(s)
Cell Differentiation , Leukemia, Promyelocytic, Acute , Benzylisoquinolines , HL-60 Cells , Humans , Tretinoin
SELECTION OF CITATIONS
SEARCH DETAIL
...